Latest financial market updates and expert analysis
Asian Markets The pharma division of Bayer has quietly become the company’s most reliable source of good news. The latest development arrived this week when Japanese regulators granted marketing approval for Sevabertinib,...
The arithmetic was supposed to be simple: the largest shareholder return in Samsung Electronics’ history should have been met with...
The tungsten producer’s capital return plan is no longer just a boardroom resolution. Almonty Industries will begin repurchasing its own...
The annual general meeting of Circus SE delivered what management would have hoped for: all eleven agenda items passed with...
The spotlight swings back to Sivers Semiconductors on Thursday, when the Stockholm-based chip specialist unveils its second-quarter results. But the...
The gap between a junior miner’s ambition and its balance sheet is rarely measured in metres of drill core. For...
The gap between geological promise and market reality has rarely been wider for Aventis Energy. Fresh assay results from its...
The arithmetic at Curis has become brutally simple. The clinical-stage biotech burned through $8.58 million in the second quarter, ended...
Thyssenkrupp shares have quietly become one of the more compelling recovery stories in European industrials, with the stock now trading...
The contrasts could hardly be starker. A Monday-morning rally sparked by a landmark Chinese listing application gave way to a...
The coming days will give Bayer investors plenty to track. The German life-science group is set to present eleven oral...
